Ascendis Pharma A/S (NASDAQ:ASND)
| Market Cap | 14.09B+8.8% |
| Revenue (ttm) | 1.05B |
| Net Income | 755.85M |
| EPS | 11.45 |
| Shares Out | 62.11M |
| PE Ratio | 16.74 |
| Forward PE | 25.09 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 18,956.398 |
| Open | 227.83 |
| Previous Close | 228.41 |
| Day's Range | 226.30 - 227.98 |
| 52-Week Range | 186.05 - 282.15 |
| Beta | 0.37 |
| Analysts | Buy |
| Price Target | 317.42(+39.92%) |
| Earnings Date | Nov 11, 2026 |
Ascendis Pharma A/S has a live Insider Score.
Scored on 2 qualifying trades from 1 insider in the last 90 days.
About ASND
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$ASND stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in ASND holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by ASND's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
ASND Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New ASND patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to ASND from public contracts
Source: USAspending.gov
ASND Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from ASND’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score